Drugs / PD-616
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01795924 | Jan 2013 → Sep 2014 | acute myeloid leukemia, myelodysplastic syndrome | Biosuccess Biotech Co., Ltd. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PD-616 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01795924 ↗ |
| Route | Intravenous | “a 1-hour intravenous (IV) infusion of PD-616” NCT01795924 ↗ |